Showing results (51-60 of 4,126) with videos related to
Sort By:
Pageof 413
Oncotarget|December 2, 2017
Whole-lesion ADC histogram and texture analysis in predicting recurrence of cervical cancer treated with CCRTJie Meng, Lijing Zhu, Li Zhu, et al.Journal of Computer Assisted Tomography|November 9, 2016
Early Changes of Irradiated Parotid Glands Evaluated by T1rho-Weighted Imaging: A Pilot StudyNan Zhou, Chen Chu, Xin Dou, et al.Nature Communications|December 3, 2022
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapyJunmeng Zhu, Yaohua Ke, Qin Liu, et al.Nature Communications|March 24, 2019
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancerNaiqing Ding, Zhengyun Zou, Huizi Sha, et al.Thoracic Cancer|October 31, 2023
Recent advances in neoantigen vaccines for treating non-small cell lung cancerShu Su, Fungjun Chen, Mingyuan Xu, et al.Melanoma Research|May 17, 2019
The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive casesYu Ren, Qing Lv, Wuheng Yue, et al.Drug News & Perspectives|December 25, 2010
Epigenetic alterations of tumor marker microRNAs: towards new cancer therapiesJia Wei, Li Xie, Miquel Taron, et al.Journal of Biomedical Nanotechnology|August 10, 2013
Tumor delivery efficiency and apoptosis enhancement by EVO nanoparticles on murie hepatic carcinoma cell line H22Quanan Zhang, Qin Liu, Jie Shen, et al.Cancer Management and Research|July 1, 2024
Efficacy and Safety of Chidamide in Combination with PD-1 Inhibitor and Radiotherapy for HER2-Negative Advanced Breast Cancer: Study Protocol of a Single Arm Prospective StudyLianru Zhang, Jie Xiao, Yishan Li, et al.Cancer Letters|August 3, 2022
Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical applicationRuihan Xu, Shiyao Du, Junmeng Zhu, et al.Pageof 413